The pregnancy-associated glycoproteins (PAGs) represent a complex group of putative aspartic peptidases expressed exclusively in the placentas of species in the Artiodactyla order. The ruminant PAGs segregate into two classes: the 'ancient' and 'modern' PAGs. Some of the modern PAGs possess alterations in the catalytic center that are predicted to preclude their ability to act as peptidases. The ancient ruminant PAGs in contrast are thought to be peptidases, although no proteolytic activity has been described for these members. The aim of the present study was to investigate (1) if the ancient bovine PAGs (PAG-2 and PAG-12) have proteolytic activity, and (2) if there are any differences in activity between these two closely related members. Recombinant bovine PAG-2 and PAG-12 were expressed in a baculovirus expression system and the purified proteins were analyzed for proteolytic activity against a synthetic fluorescent cathepsin D/E substrate. Both proteins exhibited proteolytic activity with acidic pH optima. The k cat /K m for bovine PAG-2 was 2.7=10 5 M -1 s -1 and for boPAG-12 it was 6.8=10 4 M -1 s -1 . The enzymes were inhibited by pepstatin A with a K i of 0.56 and 7.5 nM for boPAG-2 and boPAG-12, respectively. This is the first report describing proteolytic activity in PAGs from ruminant ungulates.
Introduction
Aspartic peptidases (AP) are a class of proteolytic enzymes that typically require acidic conditions for optimal activity (Davies, 1990) . Consequently, most mammalian APs tend to be found in low pH environments such as those present in gastric secretions (e.g., pepsin A, pepsin C, chymosin), lysosomes (e.g., cathepsin D) and other intracellular compartments (e.g., cathepsin E) within the cell (Davies, 1990; Dunn, 2002) . One notable exception to this trend is renin, which is operational under physiological pH conditions (Cody, 1994) .
The mammalian APs are bi-lobed proteins with both the N-terminal and C-terminal lobes being generally symmetrical to one another (Tang et al., 1973) . The lobes form a binding cleft that can accommodate a peptide substrate of seven to eight amino acids. The catalytic aspartic acid residues Asp32 and Asp215 are located at the middle of the cleft (the numbering represents that for porcine pepsin). APs are produced as zymogens/pro-enzymes (Tang et al., 1973) . Functional activation of the zymogens involves proteolytic processing of the amino-terminal propeptide.
One hallmark of the mammalian APs is the presence of highly conserved residues that flank the catalytic aspartic acids: hydrophobic-F/I/L-D-T-G-S in the N-terminal domain, and hydrophobic-D-T/S-G-S/T in the C-terminal domain (Cooper et al., 1990) . The carboxyl groups of these two aspartic acids, Asp32 and A215, interact with one another and also with a solvent water molecule by a network of hydrogen bonds. The proteolytic mechanism involves activation of the water molecule positioned between these aspartates to act as a nucleophile on the carbonyl carbon of the scissile peptide bond (Davies, 1990; Szecsi, 1992; Dunn, 2002) . The current model suggests that Asp215 acts as a general base to remove a proton from the water molecule while Asp32 donates a proton to the carbonyl oxygen of the scissile bond. In the resulting tetrahedral intermediate, Asp215 is hydrogen bonded to the attacking oxygen atom (originally part of the water molecule), while the hydrogen remaining on that oxygen is hydrogen bonded to an oxygen on Asp32 (Davies, 1990; Szecsi, 1992; Dunn, 2002) . The transfer of a proton from Asp215 to the nitrogen of the scissile peptide bond completes its hydrolysis.
The pregnancy-associated glycoproteins (PAGs) are a recently discovered family of genes that belong to the AP gene family (Xie et al., 1997a,b; Green et al., 1998; Hughes et al., 2003; Telugu et al., 2009) . They are expressed exclusively by trophoblasts -the outer cells of the placenta that are in direct contact with maternal tissues. The PAG gene family is found only in species within the Artiodactyla order (Green et al., 1998 Garbayo et al., 2000; Hughes et al., 2003) .
In ruminant ungulates, the PAG gene family is particularly large and complex. Dozens of distinct cDNAs, and numerous variants, have been cloned from cattle, sheep, goat and deer placentae (Szafranska et al., 1995; Xie et al., 1997a,b; Garbayo et al., 1998 Garbayo et al., , 2000 Green et al., 2000; Brandt et al., 2007; Telugu et al., 2009) . The PAG gene family in ruminants is composed of two evolutionarily distinct groups Hughes et al., 2000 Hughes et al., , 2003 . One grouping, the 'modern PAGs', is transcribed exclusively in specialized, moderately invasive trophoblasts known as 'binucleate' cells Hughes et al., 2003; Wooding et al., 2005) . The other grouping, known as the 'ancient PAGs', is transcribed in all trophoblast cell types Wooding et al., 2005) .
The ancient PAGs are packaged in vesicles within both mononucleate and binucleate trophoblasts and, upon secretion, they accumulate at the microvillar junction of the maternal-fetal interface (Wooding et al., 2005) . Coincident with differences in spatial expression, there are variations in temporal expression patterns as well. For example, some PAGs are expressed relatively early in gestation, while other PAGs do not appear until later in pregnancy Patel et al., 2004) . Notably, there are also obvious differences in their levels of expression. For example, bovine (bo) PAG-2 is the most abundant transcript among all the PAGs identified to date. A closely related family member, boPAG-12, is substantially less prevalent in the placenta (Telugu et al., 2009) .
Interestingly, many of the modern PAGs possess atypical residues in amino acid positions known to be involved in catalysis or in substrate-binding (Guruprasad et al., 1996; Green et al., 2000) . Because PAGs are closely related to pepsin, molecular models (based on porcine pepsin and bovine chymosin crystal structures) revealed that some of the alterations within the catalytic center are likely to render some modern PAGs incapable of acting as proteolytic enzymes Guruprasad et al., 1996; Green et al., 2000) . By contrast, most of the ancient PAGs have retained the characteristics of typical APs and are known or predicted to possess proteolytic activity (Green et al., 1998; Wooding et al., 2005; Telugu and Green, 2008) . In those PAGs suspected to be peptidases, there are differences in residues known to contribute to catalytic activity and substrate specificity, suggesting that different members of the ancient PAG grouping probably possess distinct substrate preferences and activities (Xie et al., 1991 (Xie et al., , 1997 Guruprasad et al., 1996) .
In the experiments described in this report, we sought to determine if some ancient PAGs in cattle are capable of proteolytic activity. Two paralogous ancient PAG members were chosen as the focus of the analysis -these were boPAG-2 and boPAG-12. Both of these proteins accumulate at the placenta-maternal interface (Wooding et al., 2005; unpublished data) . However, they also exhibit distinct temporal patterns of expression throughout pregnancy and they differ substantially in their relative level of transcript abundance in the placenta. boPAG-2 is the most abundantly transcribed PAG gene in cattle, whereas boPAG-12 mRNA is much less abundant -differing by as much as two to three orders of magnitude at any given time point during pregnancy (Telugu et al., 2009) .
Results

Expression and purification of recombinant boPAG-2 and boPAG-12
Recombinant bovine PAG-2 and PAG-12 were expressed in a Baculovirus insect cell expression system as fusion proteins with an N-terminal FLAG peptide engineered in-frame with the propeptide. The FLAG peptide allowed for affinity purification of fusion proteins by using an anti-FLAG M2 antibody matrix (Figure 1 ). Typical yields for the FLAG zymogens were approximately 75 mg of purified protein per one confluent (80%) 75 cm 2 culture dish. The expressed and purified proteins had the molecular weight expected of the full length fusion proteins (approximately 45 000). Accompanying the regular pro-form of boPag-12, however, was some limited glycosylation, which manifested as a somewhat higher molecular weight fraction (Figure 1 ). This probably resulted from it being cloned into the pACMP2 transfer vector that facilitates limited cytoplasmic glycosylation (Pharmingen's Baculovirus expression manual). Both PAGs as well as the higher molecular fraction of boPAG-12 were identified in Western blots by using an anti-FLAG antibody (Figure 1 ). The presence of boPAG-2 was further confirmed with a polyclonal antibody raised against boPAG-2 ( Wooding et al., 2005) .
Dependence of activities on pH
The presence of proteolytic activity and the preferred pH optima for each recombinant PAG zymogen was tested against a commercial cathepsin D/E FRET substrate. The preferred pH for maximal activity for boPAG-2 was found to be around pH 4.0, with high activity from pH 3.0 to 4.5 (Figure 2 ). Bovine PAG-12 had an optimal activity at pH 3.5, with high activity over a broader range of pH 2.5-4.5 (Figure 2 ). Some differences were notable. boPAG-12 had high activity at pH 2.5, whereas boPAG-2 had relatively little activity at this pH. The optimal activity of boPAG-2 and boPAG-12 under acidic conditions is consistent with the pH preferences of most other APs (Davies, 1990; Kay and Dunn, 1992; Szecsi, 1992; Dunn, 2002) .
Confirmation that observed activity was not from co-purifying insect cell peptidases
An immunoprecipitation experiment was performed against several insect cell lysates (with the anti-FLAG antibody) followed by peptidase assays on the immunoprecipitated material. The lysates tested represented insect cells infected with wild type virus and insect cells infected with baculovirus driving expression of recombinant equine-thyroid stimulating protein-beta (eTSHb), boPAG-2 and boPAG-20 (a modern PAG). The activity obtained from the boPAG-2 lysate was substantially greater than that was observed in the two control lysates weTSHb and cells infected with wild type baculovirus (ACNPV)x. boPAG-20 also exhibited some activity, although much less than boPAG-2 (Figure 3 ).
pH dependencies of activities of zymogen and activated forms
One hallmark of many APs is their ability to remove or displace their propeptides when placed in an acidic environment (Hazel et al., 1992; Koelsch et al., 1994; Richter et al., 1998; Wittlin et al., 1999; Barrett et al., 2004) . When boPAG-2 zymogen was incubated in activation buffer (0.25 M glycineHCl, pH 3.5) for 1 min at room temperature (RT), the ability of boPAG-2 to exhibit activity at higher pH became evident. When the preincubated protein was compared in the assay alongside boPAG-2, which had not been subjected to a preincubation step, there was a moderate increase in activity in the preincubated form. The difference in activity was most pronounced at pH 2.5 and between pH 5.5 and 6.5 ( Figure  4A ). The greatest initial rate activity was recorded within the pH optima of 3.5-4.0.
Similar measurements were made on boPAG-12. In contrast to boPAG-2, exposing the zymogen of boPAG-12 to pH 3.5 for 1 min did not result in an increased activity. However, exposing the protein to pH 3.0 for 1 min did produce a marginal increase in activity in the range from pH 2.5 to 5.0 ( Figure 4B ). Also unlike the situation that was observed with PAG-2, there was no marked improvement in activity between the preincubated protein and the intact zymogen between pH 5.5 and 6.5. These experiments were replicated multiple times and the observations were consistent among the experiments.
Comparison of steady-state kinetics of recombinant boPAG-2 and boPAG-12
The Michaelis-Menten kinetic parameters k cat , K m and k cat / K m were determined from progress curves for the full-length PAG-FLAG fusions ( Figure 5 ; Table 1 ). The K i for pepstatin Figure 3 Activity measured after an immunoprecipitation assay performed on insect cell lysates. Anti-FLAG antibody was used as a capturing antibody and protein G matrix was used as a solid support. Immunoprecipitated proteins were reacted with the cathepsin D/E FRET substrate for 1 h in pH 3.5 buffer. Liberated product was measured on a fluorescent plate reader.
Figure 4
Influence of pH on PAG-2 and PAG-12 activity. The pH dependence of the activity of recombinant boPAG-2 (A) and boPAG-12 (B) before activation (squares) and following activation (diamonds). The initial velocities (in relative fluorescent units/min) of each PAG against the fluorescent FRET-cathepsin D/E substrate at each pH were estimated from kinetic reads for 10 min.
A was also determined (Table 1) . These data revealed differences in catalytic turnover rate and efficiency toward the cathepsin D/E substrate between boPAG-2 and boPAG-12. Under identical reaction conditions, the catalytic efficiency of boPAG-2 (2.72=10 tively, being within 20% of each other indicating that the two enzymes have similar affinity for the substrate. The K i for pepstatin A was lower by more than an order of magnitude in boPAG-2 (0.56 nM) compared with boPAG-12 (7.5 nM) ( Table 1) .
Substrate preferences of boPAG-2 and boPAG-12 in comparison with porcine gastric pepsin and bovine spleen cathepsin D
To gain insight into the primary peptide specificity for boPAG-2 and boPAG-12, both full-length forms were investigated for their activity against commercially available FRET-25X peptide libraries alongside two canonical mammalian APs, porcine pepsin (from gastric mucosa) and bovine cathepsin D (from spleen). Whereas porcine pepsin and cathepsin D displayed good activity against the primary substrate libraries, boPAG-2 and boPAG-12 failed to produce reasonable velocities (Table 2 ). Of the two boPAGs, boPAG-12 exhibited a detectable, although minor, release of product. In contrast, boPAG-2 failed to exhibit detectable activity, even with relatively high concentrations of the enzymes (100 nM of active-site titrated enzyme) ( Table 2) .
Homology-based modeling of the structures of boPAG-2 and boPAG-12
The homology models for boPAG-2 and boPAG-12 were created by using crystal coordinates of human pepsin bound to pepstatin A (1psn.pdb). SWISS-MODEL (http://swissmodel. expasy.org//SWISS-MODEL.html) predicted this as one of the best templates for generating the model. Previously reported homology modeling of a modern PAG, boPAG-1, identified key residues predicted to contribute to the substrate binding pockets (Guruprasad et al., 1996) . Based on this exercise, it was determined that eight sequence positions could distinguish the active sites of pepsin, boPAG-2, boPAG-12 and homologs ( Figure 6 ). Their differing side chains could tune their respective substrate specificities. The subsites proceed in the views of Figure 6 from S 4 in the upper background towards S 3 9 (primed) in the Progress curves global fitted with k cat and K m for digestion of cathepsin D/E substrate by recombinant boPAG-2 (A) and boPAG-12 (B) at pH 4.0 and at 378C. In (A), the FRET substrate and boPAG-2 concentrations for the upper and lower series are 1 mM substrate and 5 nM boPAG-2 enzyme and 0.2 mM substrate and 2.5 nM boPAG-2 enzyme, respectively. In (B), the substrate and boPAG-12 concentrations are 0.5 mM substrate and 39 nM boPAG-12 enzyme and 0.5 mM substrate and 17 nM boPAG-12 enzyme. The lines representing each progress curve are indicated in the panels. lower foreground. The subsites were numbered according to the structure of the complex of pepsin with pepstatin (Fujinaga et al., 1995) . Either Thr12 and Gln288 or Met12 and His288 appear at S 4 in the respective homology models of boPAG-2 and boPAG-12 (toward the back at the top of Figure 6 ). Leu115 or Ala115 contribute to both S 3 and S 1 in boPAG-2 and boPAG-12, respectively. Either Ser77 or Pro77 of the flap of these two proteases contribute to both S 2 and S 1 . Either Tyr222 or His222 form the other wall of S 2 on the opposite side of the cleft ( Figure 6 ). Aromatic groups also differentiate S 1 9 with either His189 of boPAG-2 or Tyr189 of boPAG-12. Long aliphatic chains of either Met 128 or beta-branched Ile128 appear at S 2 9 in the two respective enzymes. For the contribution of flap to S 3 9, the bulky hydrophobic Phe74 of boPAG-2 is a notable contrast to the small polar Ser74 of boPAG-12.
Discussion
PAGs are related to APs and are abundantly expressed products of the placenta of ruminants and other species within the Artiodactyla order. Although PAGs have been studied extensively, their role(s) within the ungulate placenta remains largely obscure. Despite being structurally related to APs, some of the modern PAGs have accumulated mutations within key residues in and around the catalytic site, including the critical catalytic aspartates (Xie et al., 1991 (Xie et al., , 1997a Green et al., 1998) . Those modern PAGs carrying such mutations are likely to be incapable of acting as peptidases. The ancient PAGs of cattle, sheep and goats, in contrast, have all the definitive characteristics of typical APs and were predicted to have proteolytic activity (Green et al., 1998; Wooding et al., 2005) . Consequently, the aim of the present study was to address two important questions: (1) do ancient bovine PAGs have proteolytic activity and, if so, (2) how do closely related family members compare to one another with regard to kinetic parameters? To address these fundamental questions, boPAG-2 and boPAG-12 were chosen as candidates for these experiments. boPAG-2 was an obvious choice because it is the most abundantly transcribed member of the bovine PAG grouping (Telugu et al., 2009) . It is also among the first PAGs to have been identified and characterized with regard to its expression by trophoblasts and with regard to its abundant localization at the placenta-uterine interface (Xie et al., 1994; Wooding et al., 2005) . boPAG-12 is closely related to boPAG-2, sharing 89% identity at the nucleotide level and 83% identity in amino acid composition Hughes et al., 2000) . However, its level of expression is orders of magnitude below that for boPAG-2, despite that it is also localized to the placenta-uterine interface (Telugu et al., 2009) . A baculovirus insect cell expression system was chosen for expression of soluble recombinant full-length PAGs. This system is amenable to expression of acid peptidases because the cytoplasm in these cells is not strongly reducing and is maintained close to a pH of 7.0 (Medina et al., 1995) . Such conditions were predicted to help prevent the activation and subsequent loss of acid peptidases by autocatalysis. The inclusion of a synthetic coding sequence for the FLAG peptide permitted the isolation of relatively homogeneous prep- arations of purified proteins by using standard anti-FLAG affinity purification protocols. The purified full-length protein preparations were tested for optimal activity against a synthetic FRET substrate MOCAC-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2. This peptide was derived from a consensus substrate sequence for APs wLys-Pro-Ile-Gln-Phe*Nph-Arg-Leu (Nph: nitro-phenylalanine)x described elsewhere (Beyer et al., 2005) . The fluorescent substrate was initially designed and tested for utility against other well-characterized APs and cathepsins D and E (Yasuda et al., 1999) . Both boPAG-2 and boPAG-12 exhibited activity toward this substrate ( Table 1) .
The optimal activity for PAG-2 and PAG-12 was around pH 4 and 3.5, respectively (Figure 2 ). Such acidic pH optima are typical for most APs. Of the two candidate PAGs, boPAG-12 had greater activity at pH 2.5 compared with boPAG-2. When comparing their kinetic parameters from progress curves, it was apparent that boPAG-2 is almost 4-fold more active than boPAG-12 at their pH optima, despite that they are closely related and have similar affinity for the cathepsin D/E substrate. It was determined that boPAG-2 had a catalytic turnover rate more than 3 times greater than boPAG-12 under identical experimental conditions. In addition, the affinity of boPAG-2 for pepstatin A was also more than an order of magnitude greater than boPAG-12. Finally, boPAG-2 and boPAG-12 differed from one another with regard to the increase in activity observed upon a short preincubation at low pH prior to performing kinetic measurements (Figure 4) . In most APs, acidification of the protein permits an intra-or intermolecular cleavage of the propeptide (Hazel et al., 1992; Koelsch et al., 1994; Richter et al., 1998; Wittlin et al., 1999; Barrett et al., 2004) . The loss of the propeptide is thought to permit more ready access of substrate to the active site and also produces an increased mobility by SDS-PAGE as a result of the removal of the N-terminal peptide (40-50 amino acids, depending on the protein). In the preincubation experiments, boPAG-2 exhibited characteristics similar to other APs in that an increase in activity was observed after low pH exposure. boPAG-12, in contrast, exhibited little increase in activity. After extensive incubation periods at low pH it was found that boPAG-12 exhibited no shifts in mobility (i.e., no cleavage of the propeptide) by SDS-PAGE (data not shown). boPAG-2 did appear to process itself after incubation periods, but the processing did not involve the loss of the N-terminus and, instead, seemed to consist of non-specific cleavage during the incubation period (data not shown). One interpretation of these observations is that boPAG-2 and boPAG-12, while peptidases, are not able to remove their own propeptides and might require proprotein converting peptidases to perform this function.
The experiments performed with the synthetic FRET-25X substrate libraries suggested that boPAG-2 and boPAG-12 might be relatively selective with regard to the length or composition of the substrate required for detectable activity. Both porcine pepsin and bovine cathepsin D exhibited activ- Figure 6 Homology models to predict substrate binding site differences between bovine PAG-2 and PAG-12.
Residues that distinguish the active sites of boPAG-2 (A) and boPAG-12 (B) and pepsin (not shown). The homology models were constructed by using the crystal structure of mature human pepsin bound to pepstatin (PDB code 1PSN) as template with the SWISS-MODEL server (http://swissmodel.expasy.org//SWISS-MODEL.html) (Guex and Peitsch, 1997; Schwede et al., 2003; Arnold et al., 2006) . The backbone ribbon progresses through the colors of the rainbow from blue at the N-terminus to red at the C-terminus. The conserved aspartate side chains critical for peptidase activity are denoted in red. Side chains of the active site cleft differing between boPAG-2 and boPAG-12 are plotted with standard atom colors of blue for nitrogen, red for oxygen and green for carbon. The 'flap' is light blue.
ity toward these libraries in a manner consistent with what is already known about their substrate specificities (AbadZapatero et al., 1990; Scarborough and Dunn, 1994; Barrett et al., 2004) . However, both boPAG-2 and boPAG-12, when used at the same molar concentration, failed to produce significant product liberation from these libraries ( Table 2 ). This lack of activity might be reminiscent of studies performed with furin, which is fastidious when it comes to substrate sequences required for optimal activity. In those experiments, furin failed to show activity against these same substrate libraries (information provided by Peptides International, Louisville, KY, USA). The lack of activity against these libraries could be explained if the library failed to provide peptide sequences of the appropriate length or composition for optimal activity with both PAG-2 and PAG-12. However, it is worth mentioning that PAG-12 did produce at least some activity when compared with PAG-2, which suggests that PAG-12 might be more flexible with regard to its substrate requirements.
The fact that boPAG-2 and boPAG-12 have distinct pH profiles and inhibitor affinities suggests that there are likely to be differences in residues that are known to interact with the substrate to potentially stabilize it in the substrate binding cleft. In fact, such differences were revealed from comparative modeling of these proteins based on the crystal coordinates of human pepsin (Figure 6 ). For example, Thr12 in boPAG-2 that contributes to the S4 pocket is substituted by Met12 in boPAG-12. Such a change might alter the preference for a hydrophobic amino acid in the substrate occupying this subpocket. Similarly, Leu115 contributes to the S3 and S1 sites in boPAG-2, whereas the somewhat smaller Ala115 shares the comparable position in boPAG-12. Another major change was that of Ser77 in boPAG-2 by Pro77 in boPAG-12, this position is of crucial importance because it forms part of the hairpin 'flap' structure. The flap is a conserved fold in the mature molecule that arches over the substrate binding cleft and interacts and stabilizes the substrate within the substrate binding cleft (Hartsuck et al., 1992; Guruprasad et al., 1996; Richter et al., 1998; Dunn, 2002) . It makes contact with numerous residues in the substrate. Those residues at position 77 contribute to the S 2 and S 1 pockets. The replacement of Ser77 in boPAG-2 with Pro77 in boPAG-12 marks another deviation between the two PAGs that might alter the dynamics of substrate stabilization within the substrate binding cleft. Another change within the flap was the substitution of the bulky hydrophobic aromatic amino acid Phe74 in boPAG-2 with the small polar Ser74. These residues contribute to the S39 pocket. Collectively, these differences, as well as those described in the results section, suggest the following speculations on potential specificity differences between boPAG-2 and boPAG-12: boPAG-12 might be able to accommodate a bulkier side chain at P 3 and/ or P 1 of putative substrates because the Leu115 of boPAG-2 fills these pockets more than the Ala115 of boPAG-12 does. boPAG-12 would be predicted to accommodate a bulkier or more polar side chain at P 3 9 because it presents Ser74 (instead of Phe74) at S 3 9.
Although the two PAGs investigated in these experiments are active peptidases, there was little indication that they act as general peptidases, like pepsin. These data suggested that they might have somewhat refined roles in cleaving protein substrates, either within the trophoblast itself or at the fetalmaternal interface. The PAGs are secreted glycoproteins, hence they are exposed to acidic environments (potentially as low as pH 5.2) within the secretory pathway (Paroutis et al., 2004) . The PAGs might have a major role within the secretory pathway, where they might be activated by an unidentified peptidase or by auto-activation (Davies, 1990; Dunn, 2002 ). These activated PAGs might then participate in proteolytic processing of other proteins within the secretory vesicles before they exit the cell. Alternatively, they might be diverted toward the endolysosomal pathway where they could function by digestion of endocytosed agonistbound receptors or proteins taken up from uterine secretions (uterotroph). Because both the identified PAGs seem to be somewhat selective with regard to substrate preference, it might be safe to hypothesize that the ancient PAGs do not function as general degradative enzymes like cathepsins D and E, which are lysosomal and endosomal peptidases, respectively (Godbold et al., 1998; Ishidoh and Kominami, 2002) . boPAG-2 and boPAG-12 are constitutively secreted and accumulate at the maternal-fetal interface (Wooding et al., 2005) . Therefore, they might play roles as 'sheddases' to activate latent growth factors or as peptidases involved in inactivating growth factor binding proteins or other proteins within the pericellular microenvironment (Munger et al., 1998; Rifkin et al., 1999) . There are data that indicate that this environment might be slightly acidic (pH 6.5) (Punturieri et al., 2000) . In either situation, such proteolytic conversion of trophic factors might have an important role in promoting trophoblast/placentomal growth and differentiation in the ruminant placenta (Ko et al., 1991; Mathialagan and Roberts, 1994; Grundker and Kirchner, 1996; Yelich et al., 1997; Tanaka et al., 1998; Rifkin et al., 1999; Spencer and Bazer, 2004) . Future efforts will be directed toward exploring these varied possibilities.
Materials and methods
Cloning and expression of recombinant boPAG-2 and boPAG-12
The BD Baculogold Baculovirus insect cell expression system (BD Biosciences Pharmingen, San Diego, CA, USA) was used to express the recombinant proteins. boPAG-2 was cloned into the pVL92 transfer vector by using the following oligonucleotides, sense: 59 GAC TGA GCGGCCGCATGGATTACAAGGACGAT-GACGATAAGATAGTCATTTTGCCTCTA 39 and antisense: 59 GTCAGTCAGAGTCAGAGTCATGACTAGAGTCTAGATGACT-ATTACACTGCCGGAGCCAG 39. Bovine PAG-12 was cloned into the pACMP3 transfer vector with the following oligonucleotides, sense: 59 GACTCTAGAATGGATTACAAGGACGATGACGA-TAAGATAGTCATTTTGCCTCTA 39 and antisense: 59 GATCT-ATGATCTCAGTACTGCGGCCGCTCACTATTACACCTGTGCC-AGGCCAAT 39. The recombinant proteins were expressed as fusion proteins with a FLAG tag in the N-terminus of the protein. A sequence encoding FLAG peptide (DYKDDDDK), denoted as regular bold font in the sense oligonucleotide, was engineered into the sequence so that this peptide would be incorporated into the Nterminus of the proforms of both PAG-2 and PAG-12. Sequences encoding restriction enzymes (bold italicized font) Not-1 and Bgl-2 (New England Biolabs, Ipswich, MA, USA) were also engineered into the sense and antisense oligonucleotides to permit directional cloning into the corresponding transfer plasmids. Once the integrity and frame of the sequences in the transfer vectors was verified by sequencing, the vectors were transfected into Sf-9 cells along with BD Baculogold linearized Baculovirus DNA by using the BD Baculogold transfection kit according to the manufacturer's recommendations. Following transfection, the viruses were extracted, amplified and used to infect Sf-9 cells to generate recombinant proteins as described elsewhere (O'Reilly et al., 1992) . Infected cells were harvested, chilled on ice, centrifuged at 600 g for 5 min at 48C followed by two wash cycles under similar conditions with cold 1= PBS (2.68 mM KCl, 1.47 mM KH 2 PO 4 , 136.89 mM NaCl and 8.10 mM Na 2 HPO 4 , pH 7.2). The final cell pellet was stored at -808C until use.
Purification of recombinant boPAG-2 and boPAG-12
For purification of the recombinant protein, the corresponding frozen pellets were lysed on ice with I-Per insect cell protein extraction reagent (Pierce, Rockford, IL, USA). A standard cocktail of protease inhibitors, which included 0.4 mM Pefabloc SC-AEBSF (Roche Applied Science, Mannheim, Germany), 5 mg/ml aprotinin, 10 mM E-64, 1 mM EDTA along with 1 mM dithiothreitol (Sigma, St. Louis, MO, USA) was supplemented to the lysis buffer just before use. Following mixing and incubation with lysis buffer for at least 15 min on ice, the lysate was cleared by centrifugation at 15 000 g for 30 min and dialyzed overnight in a 30 kDa MWCO dialysis tubing in a buffer containing 20 mM Tris-HCl, pH 7.4, 250 mM NaCl at 48C. All purification procedures were performed in a refrigerated room at 4-68C. The dialyzed lysate was fractionated on a Sephadex-200 size exclusion column (1.5 cm=106 cm) equilibrated in 20 mM Tris-HCl, pH 7.4, 150 mM NaCl. All fractions that were determined to have the FLAG peptide present (by dot-blot with an anti-FLAG M2 antibody) were pooled and subsequently affinity purified by using anti-FLAG M2 agarose (Sigma). For affinity chromatography, the matrix was equilibrated with TBS buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4), following which the FLAG-containing protein samples were loaded twice onto the column by gravitational flow at approximately 0.2 ml/min. The column was then subjected to subsequent washes with 20 column volumes of wash buffer (20 mM Tris-HCl, 150 mM NaCl, pH 7.4), 20 column volumes of high salt buffer (20 mM Tris-HCl, 500 mM NaCl, pH 7.4) and finally 20 column volumes of high salt buffer supplemented with 0.1% Tween. The anti-FLAG M2 agarose was re-equilibrated with 10 column volumes of wash buffer to remove residual detergent, followed by 10 column volumes of pre-elution buffer (10 mM phosphate buffer, pH 7.2). The column was then eluted with 5 column volumes of 50 mM phosphate buffer, 2 M MgCl 2, pH 7.2. The protein sample was desalted by dialysis in 20 mM Tris-HCl, 250 mM NaCl, pH 8.0 and concentrated by using an Amicon Ultra-15 with Ultra cell-30 membrane (Millipore, Bedford, MA, USA). The concentrated protein samples were protected with the addition of the inhibitor cocktail and glycerol to 10% (v/v) at 48C. In most cases, the protein samples were immediately used in the assays. For longterm storage, the protein sample was stored in 50% glycerol at -808C.
Western blot analysis
For the Western blot experiments the recombinant proteins were electrophoretically transferred onto Immobilon PVDF-membrane (Millipore). The membranes were washed once with an excess of 1= TBST (10 mM Tris, 150 mM NaCl, 0.05% Tween, pH 7.5) and blocked in blocking buffer that consisted of 3% bovine serum albumin and 3% non-fat dry milk (Sigma) in 1= TBST. The blots were subsequently incubated with either a 1:1000 dilution of monoclonal anti-FLAG antibody (Sigma) or 1:2000 polyclonal anti-boPAG-2 antiserum (to further confirm the presence of boPAG-2) in blocking buffer. The blots were then washed and incubated with 1:2000 dilution of anti-mouse (for anti-flag) or anti-rabbit IgG (for boPAG-2 antiserum) conjugated to alkaline phosphatase for 45 min (Promega, Madison, WI, USA). The blots were finally washed and stained with a mixture of NBT (nitro-blue tetrazolium chloride) and BCIP (5-bromo-4-chloro-39-indolyphosphate p-toluidine salt) according to the manufacturer's instructions (Promega). The production and characterization of the boPAG-2 antiserum has been described previously (Wooding et al., 2005) .
Determining optimal pH for activity studies
To estimate the optimal pH for each PAG, the recombinant PAGs were incubated in various buffers. All pH activity experiments were conducted at 358C. A synthetic FRET (fluorescence resonance energy transfer) cathepsin D/E substrate, MOCAC-Gly-Lys-ProIle-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 wMOCAc: (7-methoxycoumarin-4-yl) acetyl; Dnp: 2,4-dinitrophenylx (Peptides International) was used to investigate the activity of boPAG-2 and boPAG-12. The substrate was dissolved in 10% DMSO to a final concentration of 200 mM, aliquoted into 10 ml samples, and stored in the dark at -808C until use. Equal amounts of protein sample (approximately 500 ng in 20 ml) were incubated with 20 mM of substrate. For determination of optimal pH, the following buffers were used: 0.1 M glycine-HCl buffer for pH 2.5, 3.0 and 3.5; 0.1 M sodium citrate-citric acid buffer for pH 4 and 4.5; 0.1 M sodium acetate-acetic acid for pH 5 and 5.5; 0.1 M Bis-Tris-HCl buffer for pH 6 and 6.5; 0.1 M HEPES for pH 7; and 0.1 M Tris-HCl for pH 7.5 and 8.0 buffers. Each reaction solution also contained NaCl at a final concentration of 0.1 M. The final volume of the reaction was maintained at 100 ml. The reaction was performed for 20 min and was terminated by addition of 900 ml of 5% trichloroacetic acid (TCA), as described previously (Yasuda et al., 1999) . The resultant mixture was further diluted to 2 ml with 5% TCA and the resultant fluorescence in the mixture was read in a PC1 Photon counting spectofluorimeter (ISS, Inc., Champaign, IL, USA) at 328 nm (excitation) and 393 nm (emission) wavelengths as described previously (Yasuda et al., 1999) . All experiments were set up in duplicate. The results from duplicate reads and from two successive experiments were used to compile the data.
Estimation of contamination by insect cell-derived acid peptidases
A parallel purification experiment was performed to confirm that the activity being measured was as a result of recombinant PAGs and not from residual insect cell-or baculovirus-derived peptidases that might have been retained after isolation of the PAGs. The lysates used for this experiment were obtained from infected insect cells expressing boPAG-2, boPAG-20 and, as a negative control, eTSHb. The boPAG-20 and eTSHb were cloned and engineered to contain a FLAG peptide in a similar approach to that used to express boPAG-2 and boPAG-12. An additional control for this experiment consisted of lysed insect cells that had been infected with wild type baculovirus (ACNPV). Then, 1 ml of each lysate was precleared by incubating with 100 ml of protein G (50%) bead slurry (BioRad, Hercules, CA, USA) on a rocker shaker at 48C for 30 min. The protein G beads were removed by centrifugation at 14 000 g at 48C for 10 min. Equal amounts (500 mg) of insect cell lysates were mixed with 5 mg of anti-FLAG antibody and rotated at 48C for 2 h. Protein G agarose matrix was added at 100 ml (50% slurry) and the resulting mixture was incubated overnight. The matrix was isolated by centrifugation and washed with 20 mM Tris-HCl, 150 mM NaCl, pH 7.4, 0.1% Tween buffer three times. After the final wash, the matrix was incubated with 0.1 M glycine-HCl buffer pH 3.5 containing 0.1 M NaCl and 20 mM fluorescent substrate (described above) in a final volume of 100 ml at 408C for 1 h. The resulting solution was centrifuged at 14 000 g for 10 min to precipitate the protein G matrix and 50 ml of supernatant was mixed with equal amounts of 10% TCA and the resultant fluorescence was measured by using a Fluroscan plate reader (Ascent, Milford, MA, USA).
Establishing pH profiles for pro-and activated forms of recombinant boPAG-2
A feature of APs is the ability to autoactivate. In most cases, this phenomenon involves removal of the propeptide by either an intraor intermolecular mechanism (Hazel et al., 1992; Koelsch et al., 1994; Richter et al., 1998; Wittlin et al., 1999; Barrett et al., 2004) . After defining activation procedures for boPAG-2 (data not shown), an optimal scheme was identified that involved adding one-third volume of 0.25 M glycine-HCl, pH 3.5 (the activation buffer) to the sample of boPAG-2 (stored in 20 mM Tris-HCl, pH 8.0, 250 mM NaCl buffer), mixing and incubating for 1 min at RT. A similar activation procedure for boPAG-12 entailed adding one-third volume of 0.25 M glycine-HCl, pH 3.0, to the sample of boPAG-12, mixing and incubating for 1 min at RT. To estimate the profile of the 'activated' protein as a function of pH and to compare it with the activity of the unactivated protein, approximately 620 ng of boPAG-2 or 540 ng of boPAG-12 total protein (either the unactivated or activated form) was incubated with 20 mM of substrate in buffers of varying pH values that were described above. The samples were placed in a 96-well Costar black microtiter plate (Corning, Corning, NY, USA) and subsequently incubated at 378C for 10 min in a Synergy-HT Fluorescent plate reader (Biotek, Winooski, VT, USA). Following the addition of substrate, the kinetic reads were obtained for the first 10 min of the reaction and the calculated initial rates were displayed as relative fluorescent units (rfu)/min. The experiment was conducted with samples in triplicate to estimate the experimental noise. The same experiment was replicated multiple times and data from a representative experiment was shown.
Determination of steady-state enzyme kinetics of boPAG-2 and boPAG-12
The steady-state enzyme kinetic parameters for boPAG-2 and bo-PAG-12 were estimated by fitting to progress curves as described elsewhere (Palmier and Van Doren, 2007) . The concentration of total protein in the purified samples was estimated by BCA protein assay (Pierce). Accurate estimates of specific activity of PAG preparations relied upon accurate active enzyme concentrations measured by active site titrations with the tight-binding inhibitor of APs known as pepstatin A, fitted as described (Knight, 1995; Copeland, 2000) . The K i for PAGs was estimated by fitting the data to the following equation by a procedure detailed in Knight (1995) :
where E o and I o are the initial concentration of enzyme and inhibitor, respectively, n o, is the initial rate of the reaction without inhibitor and 'n' is the observed velocity. Accurate measurement of k cat /K m was obtained from single progress curves collected under pseudo first-order conditions of wSx--K m and wSx))wEx, as illustrated by the slower curves in Figure 5 , fitted to the following equation:
where y is the relative fluorescence intensity, F max is the maximum change in fluorescence intensity during the reaction, E t is the enzyme active site concentration in the assay, x is time in seconds, and B is a y-axis offset correction (Orsi and Tipton, 1979; Niedzwiecki et al., 1992; Neumann et al., 2004) . Steady-state kinetics parameters, k cat and K m , were determined from two progress curves, one of which was under pseudo first-order conditions of wSx--K m and wSx))wEx. Origin Pro 7.5 (Microcal, Northampton, MA, USA) was used to obtain k cat and K m from global, nonlinear fitting of the pairs of progress curves as described by Palmier and Van Doren (2007) . All kinetic experiments were performed in 0.1 M sodium citrate-citric acid, 0.1 M NaCl (pH 4.0) buffer at 378C with the fluorescent (FRET) cathepsin D/E substrate in 3=3 mm cuvettes to reduce the path length and inner filter effect (Matayoshi et al., 1990; Lakowicz, 1999; Liu et al., 1999) . The data were obtained by monitoring product development in an SLM Aminco fluorometer (model 8100) with PC1 Photon counting upgrade (ISS, Inc.).
Comparison of aspartic protease specificity by using a FRET peptide substrate library
To gain insight into differences in substrate preferences, if any, between full-length boPAG-2 and boPAG-12, a synthetic FRET-25X substrate library (Peptides International) was employed. The library is useful for delineating optimal substrate sequence for a given peptidase, based on initial rates for the 19 different primary libraries by the peptidase, followed by more refined analysis (Tanskul et al., 2003; Hiraga et al., 2005; Namwong et al., 2006) . Pre-extracted native preparations of cathepsin D (bovine spleen) and pepsin (porcine stomach) were obtained (Sigma) and used in the assay. All preparations were active site titrated, as for the k cat and K m determinations. Equal amounts (5 nM) of active enzyme and 20 mM of substrate were used in the assay. The assay was performed in duplicate under conditions described for the kinetic analysis w0.1 M sodium citrate-citric acid, 0.1 M NaCl, pH 4.0 at 378Cx. The initial velocities were obtained against the primary substrate libraries for first 10 min of the reaction using the fluorescent plate reader.
Computational methods for generating homology models of boPAG-2 and boPAG-12
Predicted three-dimensional models for boPAG-2 and boPAG-12 were constructed by using SWISS-MODEL (http://swissmodel.expasy.org//SWISS-MODEL.html) in automated mode (Guex and Peitsch, 1997; Schwede et al., 2003; Arnold et al., 2006) . The crystal structure of human pepsin conjugated with pepstatin A (1psn.pdb) was used as a template to generate the model (Fujinaga et al., 1995; Westbrook et al., 2003) . Multiple sequence alignments of boPAG-2, boPAG-12, boPAG-1 and human pepsin were generated by using CLUSTALW (http://align.genome.jp). The template structure of human pepsin shares sequence identity of 50.6% with boPAG-2 and 53.4% with boPAG-12. Specific residues predicted to constitute the substrate binding pockets for boPAG-1 were reported elsewhere (Guruprasad et al., 1996) . The residues contributing to specific substrate binding pockets in boPAG-2 and boPAG-12 were identified from the alignments with boPAG-1. The structural views of the homology models in Figure 6 were generated by using Pymol (DeLano 2002; DeLano Scientific LLC, Palo Alto, CA, USA).
